Preterm Birth Prevention and Management Market Size, Trends, Analysis, and Outlook By Therapy (Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antibiotics Therapy, Heparin Profylaxis Therapy, Others), By Route of Administration (Oral, Parenteral, Vaginal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), by Country, Segment, and Companies, 2024-2032
The global Preterm Birth Prevention and Management market size is poised to register 6.1% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Preterm Birth Prevention and Management market across By Therapy (Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antibiotics Therapy, Heparin Profylaxis Therapy, Others), By Route of Administration (Oral, Parenteral, Vaginal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others)
The preterm birth prevention and management market is experiencing growth due to the increasing incidence of preterm labor, premature birth, and neonatal complications associated with preterm birth risk factors, maternal health conditions, and obstetric interventions, as well as advancements in prenatal care, perinatal interventions, and neonatal intensive care that aim to prolong gestation, optimize fetal development, and improve neonatal outcomes while reducing neonatal morbidity, mortality, and long-term disabilities in obstetrics/gynecology (OB/GYN) practices, maternal-fetal medicine clinics, and neonatology units. With innovations in maternal screening, progesterone supplementation, and tocolytic therapies, there is an opportunity for pharmaceutical companies and healthcare providers to offer preventive strategies and treatment options that address the underlying mechanisms and modifiable risk factors of preterm birth, from cervical length measurement and antenatal corticosteroid administration to magnesium sulfate therapy and fetal monitoring, while ensuring personalized care, shared decision-making, and multidisciplinary collaboration in perinatal care delivery. Further, the integration of prenatal education programs, community-based interventions, and telehealth services is expected to drive further market expansion and promote maternal-fetal health equity, access to care, and perinatal outcomes for women at risk of preterm birth, thereby reducing healthcare disparities, socioeconomic barriers, and adverse birth outcomes in today's maternal-infant health ecosystem.
Preterm Birth Prevention and Management Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Preterm Birth Prevention and Management market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Preterm Birth Prevention and Management survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Preterm Birth Prevention and Management industry.
Key market trends defining the global Preterm Birth Prevention and Management demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Preterm Birth Prevention and Management Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Preterm Birth Prevention and Management industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Preterm Birth Prevention and Management companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Preterm Birth Prevention and Management industry
Leading Preterm Birth Prevention and Management companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Preterm Birth Prevention and Management companies.
Preterm Birth Prevention and Management Market Study- Strategic Analysis Review
The Preterm Birth Prevention and Management market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Preterm Birth Prevention and Management industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Preterm Birth Prevention and Management Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Preterm Birth Prevention and Management Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Preterm Birth Prevention and Management market segments. Similarly, Strong market demand is encouraging Canadian Preterm Birth Prevention and Management companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Preterm Birth Prevention and Management market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Preterm Birth Prevention and Management Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Preterm Birth Prevention and Management industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Preterm Birth Prevention and Management market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Preterm Birth Prevention and Management Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Preterm Birth Prevention and Management in Asia Pacific. In particular, China, India, and South East Asian Preterm Birth Prevention and Management markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Preterm Birth Prevention and Management Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Preterm Birth Prevention and Management Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Preterm Birth Prevention and Management market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Preterm Birth Prevention and Management.
Preterm Birth Prevention and Management Market Company Profiles
The global Preterm Birth Prevention and Management market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Bayer AG, Covis Pharma GmbH, Ferring Pharmaceuticals B.V., Merck & Co. Inc, ObsEva SA, Pfizer Inc, Takeda Pharmaceutical Company Ltd, Viatris Inc.
Recent Preterm Birth Prevention and Management Market Developments
The global Preterm Birth Prevention and Management market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Preterm Birth Prevention and Management Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Therapy
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antibiotics Therapy
Heparin Profylaxis Therapy
Others
By Route of Administration
Oral
Parenteral
Vaginal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
Geographical Segmentation:
AbbVie Inc
Bayer AG
Covis Pharma GmbH
Ferring Pharmaceuticals B.V.
Merck & Co. Inc
ObsEva SA
Pfizer Inc
Takeda Pharmaceutical Company Ltd
Viatris Inc
Formats Available: Excel, PDF, and PPT
The preterm birth prevention and management market is experiencing growth due to the increasing incidence of preterm labor, premature birth, and neonatal complications associated with preterm birth risk factors, maternal health conditions, and obstetric interventions, as well as advancements in prenatal care, perinatal interventions, and neonatal intensive care that aim to prolong gestation, optimize fetal development, and improve neonatal outcomes while reducing neonatal morbidity, mortality, and long-term disabilities in obstetrics/gynecology (OB/GYN) practices, maternal-fetal medicine clinics, and neonatology units. With innovations in maternal screening, progesterone supplementation, and tocolytic therapies, there is an opportunity for pharmaceutical companies and healthcare providers to offer preventive strategies and treatment options that address the underlying mechanisms and modifiable risk factors of preterm birth, from cervical length measurement and antenatal corticosteroid administration to magnesium sulfate therapy and fetal monitoring, while ensuring personalized care, shared decision-making, and multidisciplinary collaboration in perinatal care delivery. Further, the integration of prenatal education programs, community-based interventions, and telehealth services is expected to drive further market expansion and promote maternal-fetal health equity, access to care, and perinatal outcomes for women at risk of preterm birth, thereby reducing healthcare disparities, socioeconomic barriers, and adverse birth outcomes in today's maternal-infant health ecosystem.
Preterm Birth Prevention and Management Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Preterm Birth Prevention and Management market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Preterm Birth Prevention and Management survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Preterm Birth Prevention and Management industry.
Key market trends defining the global Preterm Birth Prevention and Management demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Preterm Birth Prevention and Management Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Preterm Birth Prevention and Management industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Preterm Birth Prevention and Management companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Preterm Birth Prevention and Management industry
Leading Preterm Birth Prevention and Management companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Preterm Birth Prevention and Management companies.
Preterm Birth Prevention and Management Market Study- Strategic Analysis Review
The Preterm Birth Prevention and Management market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Preterm Birth Prevention and Management industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Preterm Birth Prevention and Management Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Preterm Birth Prevention and Management Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Preterm Birth Prevention and Management market segments. Similarly, Strong market demand is encouraging Canadian Preterm Birth Prevention and Management companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Preterm Birth Prevention and Management market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Preterm Birth Prevention and Management Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Preterm Birth Prevention and Management industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Preterm Birth Prevention and Management market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Preterm Birth Prevention and Management Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Preterm Birth Prevention and Management in Asia Pacific. In particular, China, India, and South East Asian Preterm Birth Prevention and Management markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Preterm Birth Prevention and Management Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Preterm Birth Prevention and Management Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Preterm Birth Prevention and Management market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Preterm Birth Prevention and Management.
Preterm Birth Prevention and Management Market Company Profiles
The global Preterm Birth Prevention and Management market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Bayer AG, Covis Pharma GmbH, Ferring Pharmaceuticals B.V., Merck & Co. Inc, ObsEva SA, Pfizer Inc, Takeda Pharmaceutical Company Ltd, Viatris Inc.
Recent Preterm Birth Prevention and Management Market Developments
The global Preterm Birth Prevention and Management market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Preterm Birth Prevention and Management Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Therapy
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antibiotics Therapy
Heparin Profylaxis Therapy
Others
By Route of Administration
Oral
Parenteral
Vaginal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie Inc
Bayer AG
Covis Pharma GmbH
Ferring Pharmaceuticals B.V.
Merck & Co. Inc
ObsEva SA
Pfizer Inc
Takeda Pharmaceutical Company Ltd
Viatris Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Preterm Birth Prevention and Management Market Overview and Key Findings, 2024
1.2 Preterm Birth Prevention and Management Market Size and Growth Outlook, 2021- 2030
1.3 Preterm Birth Prevention and Management Market Growth Opportunities to 2030
1.4 Key Preterm Birth Prevention and Management Market Trends and Challenges
1.4.1 Preterm Birth Prevention and Management Market Drivers and Trends
1.4.2 Preterm Birth Prevention and Management Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Preterm Birth Prevention and Management Companies
2. PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE OUTLOOK TO 2030
2.1 Preterm Birth Prevention and Management Market Size Outlook, USD Million, 2021- 2030
2.2 Preterm Birth Prevention and Management Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Therapy
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antibiotics Therapy
Heparin Profylaxis Therapy
Others
By Route of Administration
Oral
Parenteral
Vaginal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Preterm Birth Prevention and Management Market, 2025
5.2 Asia Pacific Preterm Birth Prevention and Management Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Preterm Birth Prevention and Management Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Preterm Birth Prevention and Management Market, 2025
5.5 Europe Preterm Birth Prevention and Management Market Size Outlook by Type, 2021- 2030
5.6 Europe Preterm Birth Prevention and Management Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Preterm Birth Prevention and Management Market, 2025
5.8 North America Preterm Birth Prevention and Management Market Size Outlook by Type, 2021- 2030
5.9 North America Preterm Birth Prevention and Management Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Preterm Birth Prevention and Management Market, 2025
5.11 South America Pacific Preterm Birth Prevention and Management Market Size Outlook by Type, 2021- 2030
5.12 South America Preterm Birth Prevention and Management Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Preterm Birth Prevention and Management Market, 2025
5.14 Middle East Africa Preterm Birth Prevention and Management Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Preterm Birth Prevention and Management Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Preterm Birth Prevention and Management Market Size Outlook and Revenue Growth Forecasts
6.2 US Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Preterm Birth Prevention and Management Industry Drivers and Opportunities
7. PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PRETERM BIRTH PREVENTION AND MANAGEMENT COMPANY PROFILES
8.1 Profiles of Leading Preterm Birth Prevention and Management Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Bayer AG
Covis Pharma GmbH
Ferring Pharmaceuticals B.V.
Merck & Co. Inc
ObsEva SA
Pfizer Inc
Takeda Pharmaceutical Company Ltd
Viatris Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Preterm Birth Prevention and Management Market Overview and Key Findings, 2024
1.2 Preterm Birth Prevention and Management Market Size and Growth Outlook, 2021- 2030
1.3 Preterm Birth Prevention and Management Market Growth Opportunities to 2030
1.4 Key Preterm Birth Prevention and Management Market Trends and Challenges
1.4.1 Preterm Birth Prevention and Management Market Drivers and Trends
1.4.2 Preterm Birth Prevention and Management Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Preterm Birth Prevention and Management Companies
2. PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE OUTLOOK TO 2030
2.1 Preterm Birth Prevention and Management Market Size Outlook, USD Million, 2021- 2030
2.2 Preterm Birth Prevention and Management Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Therapy
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antibiotics Therapy
Heparin Profylaxis Therapy
Others
By Route of Administration
Oral
Parenteral
Vaginal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Preterm Birth Prevention and Management Market, 2025
5.2 Asia Pacific Preterm Birth Prevention and Management Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Preterm Birth Prevention and Management Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Preterm Birth Prevention and Management Market, 2025
5.5 Europe Preterm Birth Prevention and Management Market Size Outlook by Type, 2021- 2030
5.6 Europe Preterm Birth Prevention and Management Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Preterm Birth Prevention and Management Market, 2025
5.8 North America Preterm Birth Prevention and Management Market Size Outlook by Type, 2021- 2030
5.9 North America Preterm Birth Prevention and Management Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Preterm Birth Prevention and Management Market, 2025
5.11 South America Pacific Preterm Birth Prevention and Management Market Size Outlook by Type, 2021- 2030
5.12 South America Preterm Birth Prevention and Management Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Preterm Birth Prevention and Management Market, 2025
5.14 Middle East Africa Preterm Birth Prevention and Management Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Preterm Birth Prevention and Management Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Preterm Birth Prevention and Management Market Size Outlook and Revenue Growth Forecasts
6.2 US Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Preterm Birth Prevention and Management Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Preterm Birth Prevention and Management Industry Drivers and Opportunities
7. PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PRETERM BIRTH PREVENTION AND MANAGEMENT COMPANY PROFILES
8.1 Profiles of Leading Preterm Birth Prevention and Management Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Bayer AG
Covis Pharma GmbH
Ferring Pharmaceuticals B.V.
Merck & Co. Inc
ObsEva SA
Pfizer Inc
Takeda Pharmaceutical Company Ltd
Viatris Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
